Literature DB >> 34207035

Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.

Maliha Tabassum Munir1,2, Matthew K Kay3, Min H Kang4, Md Mizanur Rahman5, Ahmed Al-Harrasi6, Mahua Choudhury3, Naima Moustaid-Moussa1,2, Fazle Hussain7, Shaikh Mizanoor Rahman6.   

Abstract

Breast cancer is the most commonly occurring cancer in women of Western countries and is the leading cause of cancer-related mortality. The breast tumor microenvironment contains immune cells, fibroblasts, adipocytes, mesenchymal stem cells, and extracellular matrix. Among these cells, macrophages or tumor-associated macrophages (TAMs) are the major components of the breast cancer microenvironment. TAMs facilitate metastasis of the breast tumor and are responsible for poor clinical outcomes. High TAM density was also found liable for the poor prognosis of breast cancer. These observations make altering TAM function a potential therapeutic target to treat breast cancer. The present review summarizes the origin of TAMs, mechanisms of macrophage recruitment and polarization in the tumor, and the contributions of TAMs in tumor progression. We have also discussed our current knowledge about TAM-targeted therapies and the roles of miRNAs and exosomes in re-educating TAM function.

Entities:  

Keywords:  angiogenesis; breast cancer; exosomes; immunosuppression; macrophage polarization; metastasis; miRNA; tumor microenvironment; tumor-associated macrophages

Year:  2021        PMID: 34207035     DOI: 10.3390/ijms22126526

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  15 in total

Review 1.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 2.  Tumour Stem Cells in Breast Cancer.

Authors:  Marina Ibragimova; Matvey Tsyganov; Nikolai Litviakov
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

Review 3.  The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.

Authors:  Kuba Retecki; Milena Seweryn; Agnieszka Graczyk-Jarzynka; Malgorzata Bajor
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 4.  Non-Coding RNAs in the Crosstalk between Breast Cancer Cells and Tumor-Associated Macrophages.

Authors:  Anna Benedetti; Chiara Turco; Giulia Fontemaggi; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-02-06

5.  M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT.

Authors:  Yingwei Xie; Zhiliang Chen; Qiyu Zhong; Zaosong Zheng; Yuqing Chen; Wentai Shangguan; Yishan Zhang; Jingying Yang; Dingjun Zhu; Wenlian Xie
Journal:  Cancer Cell Int       Date:  2021-12-18       Impact factor: 5.722

6.  Stage I-IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1+ Vessel Density.

Authors:  Annika Ålgars; Lotta Kemppinen; Ruth Fair-Mäkelä; Harri Mustonen; Caj Haglund; Sirpa Jalkanen
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 7.  Application of Microfluidic Systems for Breast Cancer Research.

Authors:  Zachary D Frankman; Linan Jiang; Joyce A Schroeder; Yitshak Zohar
Journal:  Micromachines (Basel)       Date:  2022-01-20       Impact factor: 2.891

Review 8.  Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer.

Authors:  Xia Qiu; Tianjiao Zhao; Ran Luo; Ran Qiu; Zhaoming Li
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

9.  Metabolomic Profiling of Blood-Derived Microvesicles in Breast Cancer Patients.

Authors:  Judith Buentzel; Henry Gerd Klemp; Ralph Kraetzner; Matthias Schulz; Gry Helene Dihazi; Frank Streit; Annalen Bleckmann; Kerstin Menck; Darius Wlochowitz; Claudia Binder
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

10.  The miRNA-21-5p Payload in Exosomes from M2 Macrophages Drives Tumor Cell Aggression via PTEN/Akt Signaling in Renal Cell Carcinoma.

Authors:  Zhicheng Zhang; Junhui Hu; Moe Ishihara; Allison C Sharrow; Kailey Flora; Yao He; Lily Wu
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.